HomeXERS • NASDAQ
add
Xeris Biopharma Holdings Inc
Previous close
$1.70
Day range
$1.69 - $1.74
Year range
$1.46 - $3.26
Market cap
255.60M USD
Avg Volume
1.48M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 44.39M | 33.93% |
Operating expense | 46.66M | 15.11% |
Net income | -13.39M | -3.56% |
Net profit margin | -30.16 | 22.69% |
Earnings per share | -0.10 | 0.00% |
EBITDA | -6.78M | 36.03% |
Effective tax rate | 1.73% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 72.45M | -40.60% |
Total assets | 322.60M | -6.36% |
Total liabilities | 329.38M | 10.04% |
Total equity | -6.78M | — |
Shares outstanding | 140.45M | — |
Price to book | -34.00 | — |
Return on assets | -7.57% | — |
Return on capital | -10.83% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -13.39M | -3.56% |
Cash from operations | 7.47M | 146.35% |
Cash from investing | 14.87M | 62.17% |
Cash from financing | -1.23M | -102.51% |
Net change in cash | 21.10M | -49.99% |
Free cash flow | 11.17M | 205.61% |
About
Founded
2005
Headquarters
Website
Employees
377